Nigerian pharmacists and pharmaceutical stakeholders said the country is unlikely to meet its target for local drug production by 2030 [1].
Achieving this goal is critical for reducing Nigeria's reliance on foreign medical supplies and lowering the cost of essential medicines for its population. Failure to meet the target could leave the nation vulnerable to global supply chain disruptions and currency fluctuations.
The government's objective is to produce at least 70% of locally consumed pharmaceuticals and vaccines within the country by 2030 [1]. However, professionals in the sector said this milestone is unreachable given current conditions [1].
Stakeholders cited several systemic barriers preventing the growth of the domestic industry. These challenges include inadequate infrastructure and an unreliable power supply, which are essential for the precision and stability required in drug manufacturing [1]. Additionally, the sector suffers from insufficient availability of raw materials for local production [1].
The push for local manufacturing comes as Nigeria faces a significant gap in self-sufficiency. Current estimates suggest the country has an import dependence of about 70% for its medicines [2]. This reliance on imports creates a precarious health environment where the availability of life-saving vaccines and drugs depends on external markets [2].
Industry experts said that without a comprehensive strategy to address energy and raw-material shortages, the 2030 target remains a theoretical goal rather than a practical reality [1]. The gap between the current import-heavy model and the desired 70% local production rate requires an aggressive overhaul of the industrial landscape [1, 2].
“Nigeria’s target is to produce at least 70% of locally consumed pharmaceuticals and vaccines by 2030”
The skepticism from Nigerian pharmacists highlights a disconnect between high-level policy goals and the industrial reality on the ground. Because pharmaceutical manufacturing requires stringent temperature controls and consistent electricity, the nation's power instability acts as a ceiling on growth. Until the government addresses these foundational infrastructure deficits, Nigeria will likely remain dependent on foreign imports for the majority of its healthcare needs.
